S&CO Inc. purchased a new position in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 2,298 shares of the company’s stock, valued at approximately $895,000.
Several other hedge funds also recently made changes to their positions in HCA. Brighton Jones LLC acquired a new stake in HCA Healthcare during the fourth quarter worth approximately $1,021,000. NewEdge Advisors LLC lifted its position in shares of HCA Healthcare by 11.9% during the 1st quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock valued at $1,334,000 after acquiring an additional 409 shares during the period. Sivia Capital Partners LLC increased its position in shares of HCA Healthcare by 5.5% in the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock worth $241,000 after purchasing an additional 33 shares during the period. Jump Financial LLC bought a new stake in HCA Healthcare during the second quarter worth about $2,073,000. Finally, Sei Investments Co. increased its holdings in HCA Healthcare by 56.3% in the 2nd quarter. Sei Investments Co. now owns 136,589 shares of the company’s stock valued at $52,328,000 after buying an additional 49,214 shares during the period. 62.73% of the stock is owned by institutional investors.
Analysts Set New Price Targets
HCA has been the topic of several analyst reports. UBS Group reduced their price target on shares of HCA Healthcare from $635.00 to $579.00 and set a “buy” rating on the stock in a research report on Monday, July 27th. TD Cowen cut their target price on HCA Healthcare from $500.00 to $431.00 and set a “buy” rating for the company in a research note on Monday, June 22nd. Cantor Fitzgerald decreased their price target on HCA Healthcare from $588.00 to $525.00 and set an “overweight” rating on the stock in a research note on Tuesday, July 7th. The Goldman Sachs Group reduced their price objective on HCA Healthcare from $558.00 to $485.00 and set a “buy” rating on the stock in a research note on Tuesday, July 28th. Finally, Wells Fargo & Company boosted their target price on HCA Healthcare from $369.00 to $381.00 and gave the stock an “equal weight” rating in a research note on Monday, August 3rd. Fourteen equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $465.59.
HCA Healthcare Stock Performance
Shares of NYSE:HCA opened at $404.61 on Friday. HCA Healthcare, Inc. has a 52-week low of $353.99 and a 52-week high of $556.52. The company has a market capitalization of $87.60 billion, a PE ratio of 13.55, a price-to-earnings-growth ratio of 1.40 and a beta of 1.10. The company has a fifty day moving average of $393.41 and a 200-day moving average of $446.80.
HCA Healthcare (NYSE:HCA – Get Free Report) last issued its quarterly earnings data on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, topping analysts’ consensus estimates of $7.56 by $0.03. The business had revenue of $20.23 billion for the quarter, compared to analyst estimates of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.HCA Healthcare’s quarterly revenue was up 8.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $6.84 EPS. On average, equities analysts forecast that HCA Healthcare, Inc. will post 29.47 EPS for the current fiscal year.
HCA Healthcare Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be given a dividend of $0.78 per share. The ex-dividend date is Wednesday, September 16th. This represents a $3.12 annualized dividend and a yield of 0.8%. HCA Healthcare’s dividend payout ratio (DPR) is currently 10.45%.
HCA Healthcare Profile
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
See Also
- Five stocks we like better than HCA Healthcare
- Is Best Buy the AI Winner Hiding in the Electronics Aisle?
- Applied Materials Beat Everything but Wall Street’s Expectations for Margins
- Back From Orbit, Intuitive Machines’ Share Price Enters the Buy Zone
- Texas Roadhouse and Brinker International Have the Recipe Rivals Are Missing
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
